T. Rowe Price Investment Management, Inc.

Position in ELAN — Elanco Animal Health Inc

CIK 1897612 BALTIMORE, MD

Back to ELAN Full portfolio

Position in ELAN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$828,817,607

+$31,621,138 QoQ

Shares Held

34,635,086

-1.7% QoQ

Ownership

6.93%

of shares outstanding

% of Portfolio

0.58%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 99.75421744297098.ToString("F0")% Shared 0.ToString("F0")% None 0.24578255702901963.ToString("F0")%

Common Shares in ELAN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

T. Rowe Price Investment Management, Inc. holds $877,868,421 across 3 Drug Manufacturers - Specialty & Generic names. ELAN ranks #1 (94.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ELAN	Elanco Animal Health Inc This page	34,635,086	$828,817,607
2	ALKS	Alkermes plc.	894,276	$31,621,599
3	PRGO	PERRIGO Co plc	1,622,832	$17,429,215

All Filings in ELAN

Export CSV

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$828,817,607	34,635,086	-1.7%	Shares	Sole	2026-05-15
2025-12-31	$797,196,469	35,227,418	+11.8%	Shares	Sole	2026-02-19
2025-09-30	$634,611,681	31,510,014	+61.1%	Shares	Sole	2025-11-14
2025-06-30	$279,244,571	19,554,942	+22.3%	Shares	Sole	2025-08-14
2025-03-31	$167,825,605	15,983,391	+1.9%	Shares	Sole	2025-05-14
2024-12-31	$190,014,812	15,690,736	-25.4%	Shares	Sole	2025-02-14
2024-09-30	$309,118,820	21,042,806	+115.4%	Shares	Sole	2024-11-14
2024-06-30	$140,987,737	9,770,460	+4.5%	Shares	Sole	2024-08-14
2024-03-31	$152,195,419	9,348,613	+60.3%	Shares	Sole	2024-05-15
2023-12-31	$86,904,071	5,832,488	+152.5%	Shares	Sole	2024-02-14
2023-09-30	$25,958,847	2,309,506	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.